Great to see such positive results from the preclinical trials in Newcastle! It seems it confirms some things we already suspected, which is great. I was very interested to see just how much more effective Bisantrene was against the resistant cancer cell types, which is really great news for women grappling with this awful illness. Congratulations, Race Oncology team for the great preclinical results!
Can't wait for the update on the 3 pillars strategy by the end of the quarter.
Ann: Compelling Preclinical Breast Cancer Results, page-35
-
- There are more pages in this discussion • 219 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |